Testing KDS2010 for weight loss in overweight or obese adults
Part of Hormones & metabolism clinical trials.
This study tests a new medication called KDS2010 for people who are overweight or have obesity. The goal is to see if it helps with weight loss when combined with diet and exercise.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You have a BMI of 30 or more, OR a BMI of 27 or more AND a weight-related health issue (like high blood pressure, high cholesterol, heart disease, or sleep apnea).
- You are willing to follow a reduced-calorie diet and exercise program for at least part of the study.
- You have not lost or gained more than 5% of your body weight in the last 12 weeks.
- You do not have diabetes, a history of major depression, or certain other medical conditions (like a recent stroke or cancer).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medication called MDR-001 for helping people lose weight. It is for adults who are either obese or overweight with related health issues. The goal is to see if the drug is safe and effective for weight loss.
This study tests two new experimental medications designed to help adults lose weight and improve weight-related health conditions like high blood pressure and sleep apnea. Participants will take one of these medications to see if it's safe and effective.
This early-stage study tests a new experimental medicine (NNC0113-5840) to see how it works in people who are overweight or have obesity. Researchers want to understand how the body processes this medicine and whether it's safe before testing it more widely.
This trial tests a daily pill called KAI-7535 to see if it helps people with obesity or overweight lose weight safely. It is for adults who have a body mass index (BMI) of 27 or higher and at least one weight-related health problem, such as high blood pressure or type 2 diabetes.
This trial tests a new medication called DA-1726 for people with obesity but no other major health problems. It aims to see if the drug is safe and how it works in the body. You may qualify if your body mass index (BMI) is between 30 and 45 and your weight has been stable for 3 months.
This trial tests a new injection called HS-20136-2. It looks at what happens to the drug in healthy people and in people with obesity. This helps find safe doses and see how the drug works.
Hear when a new Overweight trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.